STING1 and neoplasm: Moreover, we highlight the cGAS-STING signaling pathway as a potential mediator of the immune-activated tumor microenvironment in ARID1B-deficient cells, further enhancing our understanding of the complex interplay between genomic alterations and the immune system in cancer.